1.90
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DRRX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.88
Offen:
$1.88
24-Stunden-Volumen:
570.57K
Relative Volume:
0.59
Marktkapitalisierung:
$59.00M
Einnahmen:
$8.59M
Nettoeinkommen (Verlust:
$-17.07M
KGV:
-3.1148
EPS:
-0.61
Netto-Cashflow:
$-21.90M
1W Leistung:
+0.00%
1M Leistung:
+254.94%
6M Leistung:
+134.57%
1J Leistung:
+42.86%
Durect Corp Stock (DRRX) Company Profile
Firmenname
Durect Corp
Sektor
Telefon
(408) 777-1417
Adresse
10240 BUBB ROAD, CUPERTINO, CA
Vergleichen Sie DRRX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
DRRX
Durect Corp
|
1.90 | 59.00M | 8.59M | -17.07M | -21.90M | -0.61 |
![]()
ZTS
Zoetis Inc
|
156.76 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.48 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.91 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.61 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
306.48 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Durect Corp Stock (DRRX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-10-30 | Eingeleitet | Chardan Capital Markets | Buy |
2020-10-12 | Eingeleitet | ROTH Capital | Buy |
2020-07-31 | Eingeleitet | Oppenheimer | Outperform |
2020-01-31 | Eingeleitet | B. Riley FBR | Buy |
2019-11-18 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2019-09-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
2018-03-06 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2017-10-20 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2017-10-20 | Bestätigt | Laidlaw | Buy |
2017-10-20 | Herabstufung | Stifel | Buy → Hold |
2017-07-12 | Hochstufung | Stifel | Hold → Buy |
2017-02-28 | Fortgesetzt | H.C. Wainwright | Buy |
2016-04-25 | Eingeleitet | Rodman & Renshaw | Buy |
2015-05-01 | Bestätigt | Cantor Fitzgerald | Buy |
2015-05-01 | Bestätigt | Stifel | Buy |
2013-03-25 | Eingeleitet | Stifel | Buy |
2012-11-01 | Herabstufung | C.K. Cooper | Buy → Hold |
2012-08-17 | Eingeleitet | C.K. Cooper | Buy |
2009-06-23 | Eingeleitet | Caris & Company | Buy |
2009-03-26 | Eingeleitet | Wedbush Morgan | Hold |
Alle ansehen
Durect Corp Aktie (DRRX) Neueste Nachrichten
Is DURECT Corporation stock reversal real or fake2025 Performance Recap & Weekly High Momentum Picks - Newser
Published on: 2025-08-20 01:19:24 - Newser
Using R and stats models for DURECT Corporation forecastingTrade Performance Summary & High Win Rate Trade Alerts - Newser
Will DURECT Corporation continue its uptrend2025 Volatility Report & Weekly High Momentum Picks - Newser
Can swing trading help recover from DURECT Corporation losses2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Using data tools to time your DURECT Corporation exitEarnings Summary Report & Breakout Confirmation Alerts - Newser
Sentiment analysis tools applied to DURECT CorporationPortfolio Update Summary & Smart Investment Allocation Insights - Newser
DURECT (NASDAQ:DRRX) Stock Price Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
What does recent volatility data suggest for DURECT CorporationTrade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
Reversal indicators forming on DURECT Corporation stock2025 Trading Recap & Daily Entry Point Trade Alerts - Newser
Technical signs of recovery in DURECT CorporationPortfolio Return Report & Community Trade Idea Sharing - Newser
Market reaction to DURECT Corporation’s recent newsJuly 2025 Sector Moves & Free Community Supported Trade Ideas - Newser
Signal strength of DURECT Corporation stock in tech scannersMarket Performance Summary & Proven Capital Preservation Tips - Newser
Chart based exit strategy for DURECT CorporationDip Buying & Low Drawdown Trading Techniques - Newser
When is the best time to exit DURECT CorporationPortfolio Value Summary & Accurate Buy Signal Alerts - Newser
Durect 2025 Q2 Earnings Net Loss Narrows by 38.8% - AInvest
DURECT Corporation Reversal Rally May Surprise BearsQuarterly Market Summary & Short-Term Trading Opportunity Alerts - sundaytimes.kr
Durect: Q2 Earnings Snapshot - Connecticut Post
Published on: 2025-08-12 20:28:09 - Newser
Using economic indicators to assess DURECT Corporation potentialJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser
Bausch Health's Durect Acquisition: Strategic Valuation and Risk Mitigation in Biopharma M&A - AInvest
Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
DRRX 8-K: Announces Q2 2025 Financial Results Under Regulation FD - Stock Titan
Biotech DURECT Gets $63M Buyout Offer from Bausch Health with $350M Future Payment Potential - Stock Titan
Why DURECT Corporation stock attracts strong analyst attentionPredictive Analytics for Equity Growth Potential - Newser
How is DRRX performing? - AInvest
Is DURECT Corporation reversing from oversold territoryFree Daily Top Performing Stock Insights - Newser
DURECT (DRRX) Projected to Post Quarterly Earnings on Tuesday - Defense World
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Insider Monkey
Durect Extends Tender Offer Deadline in Merger with Bausch Health. - AInvest
Visualizing DURECT Corporation stock with heatmapsDay Trading Plan with Entry Risk Management - Newser
What is DURECT Corporation company’s growth strategyFree Investment Community - Jammu Links News
Can volume confirm reversal in DURECT CorporationSmart Forecast Signals from AI Models - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders - Eastern Progress
What makes DURECT Corporation stock price move sharplyRisk/Reward Optimization Entry Point Analysis - Newser
Does DURECT Corporation show high probability of reboundMarket Correction Proof Stock Screening Analysis - Newser
Finanzdaten der Durect Corp-Aktie (DRRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):